Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000939767-24-000122
Filing Date
2024-08-06
Accepted
2024-08-06 17:03:37
Documents
19
Effectiveness Date
2024-08-06
Reference 429
000-30235

Document Format Files

Seq Description Document Type Size
1 S-8 forms-8.htm S-8 83299
2 EX-5.1 exel20240862024s-8xex51.htm EX-5.1 7987
3 EX-23.1 exel20240862024s-8ex231.htm EX-23.1 2516
4 EX-107 exfilingfees.htm   iXBRL EX-FILING FEES 17474
5 GRAPHIC exel20240862024s-8xex51001.jpg GRAPHIC 127290
6 GRAPHIC exel20240862024s-8xex51002.jpg GRAPHIC 216555
7 GRAPHIC exel20240862024s-8xex51003.jpg GRAPHIC 183518
8 GRAPHIC exellogo201709a04a.jpg GRAPHIC 116418
  Complete submission text file 0000939767-24-000122.txt   1128065

Data Files

Seq Description Document Type Size
21 EXTRACTED XBRL INSTANCE DOCUMENT exfilingfees_htm.xml XML 4882
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 0103
Type: S-8 | Act: 33 | File No.: 333-281296 | Film No.: 241180324
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)